API Docs
All documentation Fundamental API Live (Delayed) API EOD Historical API Intraday API Real-Time (Websockets) API Financial News API Delisted Data API
Solutions
New & Popular APIs
Show all APIs Fundamental Data APIs Historical End-of-Day API Financial Events & News API Indices Historical Constituents API 40 000 Stock Market Logos API Forex Data APIs
Other products
Google Sheets Add-on Excel Add-on Coding Libraries (Python, R, etc) Wordpress Add-on
API Marketplace
Community
Academy 152 articles Forum Github 14 repos
Pricing
Overview Fundamentals API Earnings EOD API Sample Code Pricing
Register now
Free trial

No credit cards required

Get free API key
  1. Supported exchanges /
  2. NASDAQ /
  3. CVAC.NASDAQ

CureVac NV (CVAC NASDAQ) stock market data APIs

$2.84 0.02(0.7%) as of October 17, 2024
Price chart is built with Anychart

CureVac N.V., a biopharmaceutical company, focuses on developing various transformative medicines based on messenger ribonucleic acid (mRNA). It is developing prophylactic vaccines, such as mRNA-based vaccine candidates CV2CoV, which is in Phase 1 clinical trial against SARS-CoV-2; CV7202 which is in Phase 1 clinical trial for the treatment of rabies; and CVSQIV to treat multivalent seasonal influenza; Flu SV mRNA fot treating nucleotides, single antigen seasonal influenza. The company develops CV8102, which is in Phase 1 clinical trial for treating melanoma and adenoidcystic carcinoma, as well as squamous cell cancer of skin, head, and neck; and CVGBM for treating cancer. CureVac N.V. was founded in 2000 and is headquartered in Tübingen, Germany.

CureVac NV Financial Data Overview

2.82
2.84
-
2.84
2.745
2.215-6.3
637 M
224 M
65 859 K
-0.3482
2.613
Our easy-to-use no-coding solutions help you get the data effortlessly:
Excel Financial Add-In Google Sheets Financial Add-In Python
APIs SDK Windows Downloader

No long-term obligations. The minimum period is one month only. No wait. You get an API key with instructions in a few seconds right after subscription.

General: {
Code: 'CVAC',
Type: 'Common Stock',
Name: 'CureVac NV',
Exchange: 'NASDAQ',
CurrencyCode: 'USD',
CurrencyName: 'US Dollar',
CurrencySymbol: '$',
CountryName: 'USA',
CountryISO: 'US',
OpenFigi: 'BBG00W9LXXJ4',
ISIN: 'NL0015436031',
CUSIP: NULL,
CIK: '1809122',
EmployerIdNumber: NULL,
FiscalYearEnd: 'December',
IPODate: '2020-08-14',
InternationalDomestic: NULL,
Sector: 'Healthcare',
Industry: 'Biotechnology',
HomeCategory: NULL,
IsDelisted: false,
}

CureVac NV Fundamental Data is available in our Financial Data APIs

  • Net Revenue 65 859 K
  • EBITDA -270 342 016
  • Earnings Per Share -1.37
  • Income Statements
  • Balance Sheets
  • Cash flows
Fundamental data package from $59.99 See full price
Get sample
of Fundamental API Data

Get CureVac NV Earnings via APIs

  • Latest Release 2024-08-15
  • EPS/Forecast -0.26

Get CureVac NV End-of-day Data via APIs

  • End of Day, Intraday and Live APIs
  • Splits
  • Dividends

Get CureVac NV latest news via APIs

GSK plc (GSK): Why Are Hedge Funds Bullish on This Undervalued UK Stock Now?

We recently compiled a list of the 10 Best Undervalued UK Stocks To Buy Now.In this article, we are going to take a look at where GSK plc (LON:GSK) stands against the other undervalued UK stocks. The...

Down -14.25% in 4 Weeks, Here's Why You Should You Buy the Dip in CureVac N.V. (CVAC)

CureVac N.V. (CVAC) has been on a downward spiral lately with significant selling pressure. After declining 14.3% over the past four weeks, the stock looks well positioned for a trend reversal as it i...
News API is available at any package from $19.99 See full price
Get sample of News API
Do you have any questions?
support@eodhistoricaldata.com